1. Home
  2. AMPH vs AXGN Comparison

AMPH vs AXGN Comparison

Compare AMPH & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$25.25

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Axogen Inc.

AXGN

Axogen Inc.

HOLD

Current Price

$30.32

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMPH
AXGN
Founded
1996
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
AMPH
AXGN
Price
$25.25
$30.32
Analyst Decision
Buy
Strong Buy
Analyst Count
6
9
Target Price
$31.00
$33.67
AVG Volume (30 Days)
374.8K
992.8K
Earning Date
11-06-2025
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.27
N/A
Revenue
$723,305,000.00
$214,709,000.00
Revenue This Year
$1.35
$21.57
Revenue Next Year
$5.10
$15.79
P/E Ratio
$11.14
N/A
Revenue Growth
N/A
18.72
52 Week Low
$20.39
$9.22
52 Week High
$45.39
$34.24

Technical Indicators

Market Signals
Indicator
AMPH
AXGN
Relative Strength Index (RSI) 42.84 64.32
Support Level $25.22 $28.88
Resistance Level $27.84 $34.24
Average True Range (ATR) 0.80 1.54
MACD -0.22 -0.16
Stochastic Oscillator 2.56 49.59

Price Performance

Historical Comparison
AMPH
AXGN

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

Share on Social Networks: